Paclitaxel News and Research

RSS
Paclitaxel is a drug used to treat breast cancer, ovarian cancer, and AIDS-related Kaposi sarcoma. It is also used together with another drug to treat non-small cell lung cancer. Paclitaxel is also being studied in the treatment of other types of cancer. It blocks cell growth by stopping cell division and may kill cancer cells. It is a type of antimitotic agent. Also called Taxol.

The Paclitaxel compound is extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity. Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division. This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). Check for active clinical trials or closed clinical trials using this agent.
Regulating gut bacteria could calm chemo side effects, reduce cognitive problems

Regulating gut bacteria could calm chemo side effects, reduce cognitive problems

Atlantic Health System Cancer Care enrolling patients in five pancreatic cancer studies

Atlantic Health System Cancer Care enrolling patients in five pancreatic cancer studies

NCCN ORP plans to support phase II randomized trial for lung cancer patients

NCCN ORP plans to support phase II randomized trial for lung cancer patients

Researchers discover new chemical weapon to fight against cancer

Researchers discover new chemical weapon to fight against cancer

Newly discovered organelle could help prevent cancer

Newly discovered organelle could help prevent cancer

Oncolytics Biotech and PrECOG collaborate to study metastatic breast cancer

Oncolytics Biotech and PrECOG collaborate to study metastatic breast cancer

Paclitaxel-coated devices used for widening blocked arteries not linked to increased mortality

Paclitaxel-coated devices used for widening blocked arteries not linked to increased mortality

Study on gene mutations may lead to better diagnosis and treatment for cancer

Study on gene mutations may lead to better diagnosis and treatment for cancer

Study links FAK protein to chemotherapy resistance in ovarian cancer

Study links FAK protein to chemotherapy resistance in ovarian cancer

Nab-Paclitaxel drug combo reduces risk of  breast cancer recurrence

Nab-Paclitaxel drug combo reduces risk of breast cancer recurrence

Researchers demonstrate the effectiveness of new bladder cancer treatment

Researchers demonstrate the effectiveness of new bladder cancer treatment

SU2C Dream Team to develop new drug combination to stop spread of breast cancer

SU2C Dream Team to develop new drug combination to stop spread of breast cancer

Longer-lived, but less toxic drug may work better for pancreatic cancer

Longer-lived, but less toxic drug may work better for pancreatic cancer

New drug-delivery system disguises chemotherapeutics as fat to outsmart tumors

New drug-delivery system disguises chemotherapeutics as fat to outsmart tumors

New drug combinations and dosing schedules improve outlook in advanced colon cancer

New drug combinations and dosing schedules improve outlook in advanced colon cancer

Processed aconite root could relieve neuropathic pain in murine peripheral neuropathy

Processed aconite root could relieve neuropathic pain in murine peripheral neuropathy

Increased stress hormones accelerate breast cancer metastasis

Increased stress hormones accelerate breast cancer metastasis

Hypertension drug may improve effectiveness of ovarian cancer treatment

Hypertension drug may improve effectiveness of ovarian cancer treatment

Clinigen, Accord Healthcare extend exclusive European clinical trial supply agreement

Clinigen, Accord Healthcare extend exclusive European clinical trial supply agreement

Study uncovers how tumors backfire on neoadjuvant chemotherapy

Study uncovers how tumors backfire on neoadjuvant chemotherapy